LOINCActiveBoth

LOINC Code 73821-1: Chr X and Y aneuploidy risk Dosage of chromosome-specific cfDNA Qn (cfDNA)

73821-1 is a LOINC code used to identify Chr X and Y aneuploidy risk Dosage of chromosome-specific cfDNA Qn (cfDNA) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Fetal chromosome X & Y aneuploidy risk. It is commonly used with the system or sample type Plas.cfDNA.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Fetal chromosome X & Y aneuploidy risk. It is commonly used with the system or sample type Plas.cfDNA.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Dosage of chromosome specific cf DNA

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
  • Fetal chromosome X & Y aneuploidy risk
  • The probability risk for sex chromosome (X & Y) aneuploidy can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
  • Chr X + Y aneup; Chr X + Y aneup risk; Chromosom; Chromosomes; Molecular pathology; MOLPATH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Spec

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Chr X and Y aneuploidy risk Dosage of chromosome-specific cfDNA Qn (cfDNA)Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAFet Chr X + Y aneup risk Plas.cfDNA QnFetal chromosome X & Y aneuploidy riskMOLPATHFetal Chromosome X and Y Aneuploidy RiskLikelihood

Frequently asked questions

Code details

Code73821-1
SystemLOINC
Display nameChr X and Y aneuploidy risk Dosage of chromosome-specific cfDNA Qn (cfDNA)
DescriptionFetal chromosome X & Y aneuploidy risk
Short nameFet Chr X + Y aneup risk Plas.cfDNA Qn
ComponentFetal chromosome X & Y aneuploidy risk
PropertyLikelihood
TimingPt
System (specimen)Plas.cfDNA
ScaleQn
MethodDosage of chromosome specific cf DNA
ClassMOLPATH
Example unitsRisk
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.44
Last changed2.73

Consumer names

Fetal Chromosome X and Y Aneuploidy Risk

Part names

Fetal chromosome X & Y aneuploidy riskLikelihoodPtPlas.cfDNAQnDosage of chromosome specific cf DNAFetal Chromosome X and Y aneuploidy riskPoint in time (spot)Plasma cell-free DNADosage of chromosome-specific cfDNA

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.